Cytosol concentrations of CD44 isoforms in breast cancer tissue

International Journal of Cancer

Volumn 79, Issue 5, 1998, Pages 541-545

  Hefler, Lukas ^a   Tempfer, Clemens ^a   Haeusler, Guenther ^a   Kucera, Elisabeth ^a   Mayerhofer, Klaus ^a   Zeillinger, Robert ^a   Reinthaller, Alexander ^a   Kainz, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER STATISTICS; CORRELATION FUNCTION; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; ANTIGENS, CD44; BREAST NEOPLASMS; CYTOSOL; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROADENOMA; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0031667709     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981023)79:5<541::AID-IJC17>3.0.CO;2-4     Document Type: Article

References (28)

1. BECK, T., WEIKEL, W., BRUMM, C., WILKENS. C., FOLLOW, K. and KNAPSTEIN, PG., Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay. Gynecol. Oncol., 53, 220-227 (1994).
2. BIESTERFELD, S., VEUSKENS, U., SCHMITZ, F.J., AMO-TAKYI B. and BOCKING, A., Interobserver reproducibility of immunocytochemical estrogen and progesterone receptor status assesment in breast cancer. Anticancer Res., 16, 2497-2500 (1996).
3. DALL, P., HEIDER, K.H., HEKELE, A., VON MINCKWITZ. G., KAUFMANN, M., PONTA, H. and HERRLICH, P., Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal epithelium. Cancer Res., 54, 3337-3341 (1994).
4. DALL, P., HEIDER, K.H., SINN, H.P., SKROCH-ANGEL, P., ADOLF, G., KAUFMANN, M., HERRLICH, P. and PONTA, H., Comparison of immunohistochemical and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer, 60, 471-474 (1995).
5. Fox, S.B., GATTER, K.C., JACKSON, D.G., SCREATON, D.G., BELL, M.V., BELL, J.I., HARRIS, A.L., SIMMONS, D. and FAWCETT, J., CD44 and cancer screening. Lancet, 342, 548-549 (1993).
6. FRIEDRICHS, K., FRANKE, F., LISBOA, B.W., KUGLER, G., GILLE, I., TERPE, H.J., HOLZEL, F., MAASS, H. and GUNTHERT, U., CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res., 55, 5424-5433 (1995a).
7. FRIEDRICHS, K., KUEGLER, G., FOLKER, F, TERPE, H.J., ARLT, J., REGIDOR, P.A. and GUNTHERT, U., CD44 isoforms in prognosis of breast cancer. Lancet, 345, 1237 (1995b).
8. GUNTHERT, U., STAUDER. R., MAYER, B., TERPE, H.J., FINKE, L. and FRIEDRICHS, K., Are CD44 variant isoforms involved in human tumour progression? Cancer Surv., 24, 19-42 (1995).
9. GURIEC, N., GAIRARD, B., MARCELLINI, L., WILK, A., CALDEROLI, H., RENAUD, R., BERGERAT, J.P. and OBERLING, F., Expression of CD44 spliced variants with both exons v9 and v10 in primary N(-)M(-) breast carcinomas correlates with metastasis. Int. J. Oncol., 10, 171-175 (1997).
10. HEIDER, K.H., DAMMRICH, J., SKROCH ANGEL, P., MULLER HERMELINK, H.K., VOLLMERS, H.P., HERRLICH, P. and PONTA, H., Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53, 4197-4203 (1993).
11. HOLE, A.K., BELKHIRI, A., SNELL, L.S. and WATSON, P.H., CD44 variant expression and estrogen receptor status in breast cancer. Breast Cancer Res. Treat., 43, 165-173 (1997).
12. HONG, R.L., Pu, Y.S., HSIEH, T.S., CHU, J.S. and LEE, W.J., Expression of E-cadherin and exon v5-containing isoforms of CD44 and their prognostic value in human transitional cell carcinoma. J. Urol., 153, 2025-2028 (1995).
13. HONN, K.V., POWERS, W.E. and SLOANE, B.F. (eds.), Mechanisms of cancer metastasis: potential therapeutic implications, M. Nijhoff, New York (1986).
14. INCARDONA, F., LEWALLE, J.M., MORANDI, V., LAMBERT, S., LEGRAND, Y., FOIDART, J.M. and LEGRAND, C., Thrombospondin modulates human breast adenocarcinma cell adhesion to human vascular endothelial cells. Cancer Res., 55, 166-173 (1995).
15. JOENSUU, H., KLEMI, P.J., TOIKKANEN, S. and JALKANEN, S., Glycoprotein CD44 expression and its association with survival in breast cancer. Amer. J. Pathol., 143, 867-874 (1993).
16. KAUFMANN, M., HEIDER, K.H., SINN, H.P., VON MINCKWITZ, G., PONTA, H. and HERRLICH, P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
17. KOLI, K.M. and ARTEAGA, C.L., Predominant cytosolic localization of type II transforming growth factor β receptors in human breast carcinoma cells. Cancer Res., 57, 970-977 (1997).
18. LACKNER, C., MOSER, R., BAUERNHOFER, T., WILDERS-TRUSCHNIG, M., SAMONIGG, H., BERGHOLD, A. and ZATLOUKAL, K., Soluble CD44v5 and CD44v6 in serum of patients with breast cancer. Correlation with expression of CD44v5 and v6 variants in primary tumors and location of distant metastasis. Breast Cancer Res. Treat., 47, 29-40 (1998).
19. LUQMANI, Y.A., TEMMIM, L., MEMON, A., ALI, M.A. and PARKAR, A.H., Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts. Int. J. Cancer, 71, 526-538 (1997).
20. MATSAMURA, Y. and TARIN, D., Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
21. MATSUURA, N., NARITA, T., MITSUOKA, C., KIMURA, N., KANNAGI, R., IMAI, T., FUNAHASHI, H. and ZTAKAGI, H., Increased levels of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn. J. clin. Oncol, 27, 135-139 (1997).
22. MIRECKA, J., MARX, D. and SCHAUER, A., Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer. Anticancer Res., 15, 1459-1465 (1995).
23. PUJOL, P., MAUDELONE, T., DAURES, J.P., ROUANET, P., PUJOL, H. and ROCHEFORT, H., A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer, 71, 2006-2112 (1993).
24. REGIDOR, P.A., CALLIES, R., REGIDOR, M., GUNTHERT, U., ZOLLER, M. and SCHINDLER, A.E., Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Arch. Gynecol. Obstet., 258, 125-135 (1996).
25. TAKEUCHI, K., YAMAGUCHI, A., URANO, T., GOI, T., NAKAGAWARA, G. and SHIKU, H., Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn. J. Cancer Res., 86, 292-297 (1995).
26. TEMPFER, C., LOESCH, A., HEINZL, H., HAEUSLER, G., HANZAL, E., KOELBL, H., BREITENECKER, G. and KAINZ, CH., Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur: J. Cancer, 32, 2023-2025 (1996).
27. TERPE, H.J., STARK, H., PREHM, P. and GUNTHERT, U., CD44 vaníant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry, 101, 79-89 (1994).
28. WAYNER, E.A. and CARTER, W.G., Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J. Cell Biol., 105. 1873-1884 (1987).